Literature DB >> 2971349

Ligand-receptor interactions involved in the stimulation of Swiss 3T3 fibroblasts by insulin-like growth factors and insulin.

A N Corps1, K D Brown.   

Abstract

1. The binding of 125I-labelled insulin-like growth factor 1 (125I-IGF-1) to Swiss mouse 3T3 fibroblasts was time- and concentration-dependent. Unlabelled IGF-1 had a slightly higher potency than multiplication-stimulating activity (MSA) in inhibiting the binding of 125I-IGF-1, and insulin gave a parallel inhibition curve at 300-1000-fold lower potency. Chemical cross-linking of bound 125I-IGF-1 to its receptors, followed by polyacrylamide-gel electrophoresis under reducing conditions, revealed a major band of Mr 130,000, the labelling of which was inhibited by IGF-1 or high concentrations of insulin. 2. The binding of 125I-IGF-1 was not affected by either co-incubation or preincubation of the cells with a range of heterologous growth factors and mitogens. However, IGF-1 and MSA each induced down-regulation of 125I-IGF-1 binding sites. 3. The maximal stimulations of DNA synthesis induced by IGF-1, MSA and insulin, in the presence of a synergizing mitogen, were similar. The dose-response curve for insulin was not parallel to those for IGF-1 and MSA; in particular, low concentrations of insulin induced a greater stimulation than expected on the basis of its potency in the inhibition or down-regulation of 125I-IGF-1 binding. 4. The preincubation of 125I-IGF-1 with Swiss 3T3 cells at 37 degrees C decreased its ability to bind to a second batch of cells. This inactivation did not occur when the preincubation was performed at 4 degrees C or in the presence of cycloheximide. Chemical cross-linking revealed that the cells released an IGF-binding protein, giving a complex of Mr about 48,000. 5. It is concluded that type I IGF receptors mediate the stimulation of Swiss 3T3 cells by insulin-like mitogens, but that insulin probably stimulates the cells through insulin receptors. The cells can modulate the amount of ligand binding, both by down-regulation of the receptors and by the secretion of an IGF-binding protein.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2971349      PMCID: PMC1149114          DOI: 10.1042/bj2520119

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  A peptide that inhibits the mitogenic stimulation of Swiss 3T3 cells by bombesin or vasopressin.

Authors:  A N Corps; L H Rees; K D Brown
Journal:  Biochem J       Date:  1985-11-01       Impact factor: 3.857

Review 2.  Actions of insulin-like growth factors.

Authors:  E R Froesch; C Schmid; J Schwander; J Zapf
Journal:  Annu Rev Physiol       Date:  1985       Impact factor: 19.318

3.  Substrate specificities of insulin and epidermal growth factor receptor kinases.

Authors:  H H Klein; G R Freidenberg; R Cordera; J M Olefsky
Journal:  Biochem Biophys Res Commun       Date:  1985-02-28       Impact factor: 3.575

4.  Follicle-stimulating hormone enhances somatomedin C binding to cultured rat granulosa cells. Evidence for cAMP dependence.

Authors:  E Y Adashi; C E Resnick; M E Svoboda; J J Van Wyk
Journal:  J Biol Chem       Date:  1986-03-25       Impact factor: 5.157

5.  Cultured fibroblast monolayers secrete a protein that alters the cellular binding of somatomedin-C/insulinlike growth factor I.

Authors:  D R Clemmons; R G Elgin; V K Han; S J Casella; A J D'Ercole; J J Van Wyk
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

6.  Epidermal growth factor and a new derivative. Rapid isolation procedures and biological and chemical characterization.

Authors:  C R Savage; S Cohen
Journal:  J Biol Chem       Date:  1972-12-10       Impact factor: 5.157

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  The subunit structures of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor.

Authors:  J Massagué; M P Czech
Journal:  J Biol Chem       Date:  1982-05-10       Impact factor: 5.157

9.  Insulin-like growth factor II binding to the type I somatomedin receptor. Evidence for two high affinity binding sites.

Authors:  S J Casella; V K Han; A J D'Ercole; M E Svoboda; J J Van Wyk
Journal:  J Biol Chem       Date:  1986-07-15       Impact factor: 5.157

10.  The subunit structure of the high affinity insulin receptor. Evidence for a disulfide-linked receptor complex in fat cell and liver plasma membranes.

Authors:  P F Pilch; M P Czech
Journal:  J Biol Chem       Date:  1980-02-25       Impact factor: 5.157

View more
  11 in total

1.  Role of the PI3-kinase signaling pathway in trafficking of the surfactant protein A receptor P63 (CKAP4) on type II pneumocytes.

Authors:  Altaf S Kazi; Jian-Qin Tao; Sheldon I Feinstein; Li Zhang; Aron B Fisher; Sandra R Bates
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-09-24       Impact factor: 5.464

2.  Regulation of protein synthesis in Swiss 3T3 fibroblasts. Rapid activation of the guanine-nucleotide-exchange factor by insulin and growth factors.

Authors:  G I Welsh; C G Proud
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

3.  Overexpression of the human insulinlike growth factor I receptor promotes ligand-dependent neoplastic transformation.

Authors:  M Kaleko; W J Rutter; A D Miller
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

4.  Endothelin stimulates DNA synthesis in Swiss 3T3 cells. Synergy with polypeptide growth factors.

Authors:  K D Brown; C J Littlewood
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

Review 5.  From animal to molecule: aspects of the biology of insulin-like growth factors.

Authors:  R S Gilmour; C G Prosser; I R Fleet; L Cocco; J C Saunders; K D Brown; A N Corps
Journal:  Br J Cancer Suppl       Date:  1988-12

6.  Reconstitution of an insulin signaling pathway in Xenopus laevis oocytes: coexpression of a mammalian insulin receptor and three different mammalian hexose transporters.

Authors:  J C Vera; O M Rosen
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

7.  Immunocytochemical evaluation of protein kinase C translocation to the inner nuclear matrix in 3T3 mouse fibroblasts after IGF-I treatment.

Authors:  N Zini; A M Martelli; L M Neri; A Bavelloni; P Sabatelli; S Santi; N M Maraldi
Journal:  Histochem Cell Biol       Date:  1995-06       Impact factor: 4.304

8.  Insulin and insulin-like-growth-factor-I (IGF-I) receptors in Xenopus laevis oocytes. Comparison with insulin receptors from liver and muscle.

Authors:  P Hainaut; A Kowalski; S Giorgetti; V Baron; E Van Obberghen
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

9.  Changes in the components of a nuclear inositide cycle during differentiation in murine erythroleukaemia cells.

Authors:  N Divecha; A J Letcher; H H Banfic; S G Rhee; R F Irvine
Journal:  Biochem J       Date:  1995-11-15       Impact factor: 3.857

10.  Differential signalling potential of insulin- and IGF-1-receptor cytoplasmic domains.

Authors:  R Lammers; A Gray; J Schlessinger; A Ullrich
Journal:  EMBO J       Date:  1989-05       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.